Ronapreve® (casirivimab and imdevimab) 120 mg/ml solution for injection or infusion: Important information for healthcare professionals about the indications, in-use storage conditions and expiry date of the 20 ml vial packs
To facilitate patient access to treatment, an additional Batch Specific Variation for supply of cartons of 20 ml vials of ‘Casirivimab and Imdevimab 120 mg/ml Concentrate for Solution for Infusion’ has been approved by MHRA, in addition to first batch of cartons of 6 ml vials.
Source:
Roche
SPS commentary:
The communication contains information on the expiry dates over-labelled on the cartons of 20 ml vials; the expiry dates printed on the vials should be disregarded- a condition of approval is that stock expires within a year of manufacture. Also detailed are the authorised indications and in-use storage conditions for cartons of 20 ml vials.